Johnson & Johnson (“J&J”) has reached a four million settlement with the state of Oregon to resolve allegations that J&J improperly marketed its DePuy ASR metal-on-metal hip implants.  J&J has recalled 93,000 ASR hip implants, which had a 12% failure rate in five years.

David Hart, Oregon’s Assistant Attorney General stated that Oregon began looking into the issue in 2011 and had launched an investigation about a year before the start of a multi-state investigation.  Hart further stated that DePuy began settlement discussions with state officials after they had prepared a civil complaint.

Oregon’s attorney general, Ellen Rosenblum noted that DePuy sold 432 of the ASR hip devices in the state from 2005, when they were first introduced in the United States.  “Oregonians in need of a hip replacement deserve to know that the artificial hip they are contemplating in fact has the qualities, and benefits, that a company advertises,” according to Ellen Rosenblum.

In fact, more states are taking the initiative to file individual lawsuits against drug and medical device manufacturers over deceptive marketing. For example, both Kentucky and Maryland filed separate lawsuits against GlaxoSmithKline (GSK) in February, over the drug Avandia. They accused GSK of deceptively marketing the popular diabetes drug, which has now been linked to an increased risk for strokes and heart attacks.

Last year, J&J announced a settlement agreement under which it would pay approximately $2.5 billion to compensate thousands of patients that were claiming injuries from the implants.

 

Written by:

Published In:

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Searcy Denney Scarola Barnhart & Shipley | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »

All the intelligence you need, in one easy email:

Great! Your first step to building an email digest of JD Supra authors and topics. Log in with LinkedIn so we can start sending your digest...

Sign up for your custom alerts now, using LinkedIn ›

* With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name.
×
Loading...
×
×